Literature DB >> 1916495

Self-dilatation of oesophageal strictures.

M H Robinson1, M W Gear.   

Abstract

A new technique for the management of upper and mid-oesophageal benign strictures is reported. A deflated oesophageal balloon catheter coated with steroid paste is passed by the patient through the stricture, the balloon is inflated and then withdrawn. This technique can be used for both strictures caused by tablet or corrosive damage that recur rapidly and where stricturing is the result of a chronic disease not amenable to medical or surgical treatments. Three patients in who this technique has been used with satisfactory patient tolerance and compliance and good relief of symptoms are reported.

Entities:  

Mesh:

Year:  1991        PMID: 1916495      PMCID: PMC1379054          DOI: 10.1136/gut.32.9.1076

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  6 in total

1.  The treatment of urethral stricture: transurethral injection of triamcinolone.

Authors:  P W Hebert
Journal:  J Urol       Date:  1972-11       Impact factor: 7.450

2.  Treatment of acquired subglottic stenosis.

Authors:  L G Waggoner; W M Belenky; C E Clark
Journal:  Ann Otol Rhinol Laryngol       Date:  1973 Nov-Dec       Impact factor: 1.547

3.  The expeimental treatment of esophageal strictures by intralesional steroid injections.

Authors:  K W Ashcraft; T M Holder
Journal:  J Thorac Cardiovasc Surg       Date:  1969-11       Impact factor: 5.209

4.  The treatment of patients with esophageal strictures by local steroid injections.

Authors:  T M Holder; K W Ashcraft; L Leape
Journal:  J Pediatr Surg       Date:  1969-12       Impact factor: 2.545

5.  Oesophageal involvement in benign mucous membrane pemphigoid.

Authors:  M A Al-Kutoubi; C Eliot
Journal:  Clin Radiol       Date:  1984-03       Impact factor: 2.350

6.  Balloon dilatation of benign and malignant esophageal strictures. Blind retrograde balloon dilatation.

Authors:  D Y Graham; J L Smith
Journal:  Gastrointest Endosc       Date:  1985-06       Impact factor: 9.427

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.